Kenya received a further 180,000 doses of AstraZeneca vaccine on Friday in a boost to ongoing vaccination efforts amid increased Covid-19 cases across the country.
The latest consignment, which was a donation from the Greek government, pushes the number of vaccines received in the country to 2,323,100.
Speaking at JKIA after receiving the consignment, National Taskforce on Vaccine Deployment Chair Dr. Willis Akhwale said the donation was a welcome boost to the ongoing vaccination exercise.
Akhwale said the government expects to have vaccinated 10 million people by the end of this year.
Speaking during the ceremony, Deputy head of mission at the Embassy of Greece in Kenya Counsellor Sotirios Demestichas, said the donation was a demonstration of the cordial relations between Kenya and Greece. EU deputy head of delegation Katrin Susanna HAGEMANN was among those who attended the ceremony.
As of August 5th, 2021, a total of 1,768,519 vaccines had been administered across the country with total first doses standing at 1,084,013 while 684,506 second doses had been administered. The proportion of adults fully vaccinated in the country stood at 2.5% by close of Friday.
The first vaccination began on 5th March 2021 with county vaccinations kicking off on 8th of March 2021. The second dose vaccination began on 28th May 2021. The government is conducting the vaccination free of charge.
Health Cabinet Secretary Mutahi Kagwe has indicated that more vaccine doses will be arriving in the country to boost the ongoing vaccination campaign.
The roll out of the national vaccination campaign is being led by the Ministry of Health, with support from WHO, UNICEF, Gavi and other partners.
The Government of Kenya is currently prioritising second doses for health workers, teachers, other essential workers and people aged over 58.
Distributed by APO Group on behalf of Ministry of Health, Kenya.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
